Concepedia

Author

Yongxian Hu

Zhejiang UniversityORCID

Also Known As

Hu, Yongxian, Y Hu, Y X Hu, Y. Hu, Ying‐Qing Hu, Yong'an Hu, Yong-Xian Hu, Yong-xian Hu, YongXian Hu, Yongan Hu

261

Publications

3.3K

Citations

29

H-Index

78

Concepts

All Affiliations

Zhejiang UniversityFirst Affiliated Hospital Zhejiang UniversityZhejiang Chinese Medical UniversityZhejiang LabTongji University
YH

About

Yongxian Hu is an author at Zhejiang University specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

18

775

2

Health Sciences

7

7

332

3

Engineering

1

1

19

4

Natural Sciences

1

1

42

5

Biochemistry

1

1

79

Yongxian Hu

×

47

Publications

2.4K

Citations

23

H-Index

YearCitations

Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL

Jiqin Zhang, Yongxian Hu, Jiaxuan Yang,

Nature

2022

326

CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Yongxian Hu, Yali Zhou, Mingming Zhang,

Clinical Cancer Research

2021

263

Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study

Yongxian Hu, Yali Zhou, Mingming Zhang,

Cell Research

2022

178

GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial

Mingming Zhang, Guoqing Wei, Linghui Zhou,

The Lancet Haematology

2023

156

Potent Anti-leukemia Activities of Chimeric Antigen Receptor–Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic Leukemia

Yongxian Hu, Zhao Wu, Yi Luo,

Clinical Cancer Research

2016

133

Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Predicting the Adverse Effects of Chimeric Antigen Receptor T Cell Therapy in Patients with Non-Hodgkin Lymphoma

Jiasheng Wang, Yongxian Hu, Shuye Yang,

Biology of Blood and Marrow Transplantation

2019

127

Efficacy and safety of CD19-specific CAR T cell–based therapy in B-cell acute lymphoblastic leukemia patients with CNSL

Yuekun Qi, Mingfeng Zhao, Yongxian Hu,

Blood

2022

88

Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study

Houli Zhao, Jieping Wei, Guoqing Wei,

Journal of Hematology & Oncology

2020

79

Mitochondrial isocitrate dehydrogenase impedes CAR T cell function by restraining antioxidant metabolism and histone acetylation

Xiaohui Si, Mi Shao, Xinyi Teng,

Cell Metabolism

2024

79

Single-Cell Transcriptomic Analysis Reveals BCMA CAR-T Cell Dynamics in a Patient with Refractory Primary Plasma Cell Leukemia

Xue Li, Xin Guo, Yuqing Zhu,

Molecular Therapy

2020

67

Page 1